ReportsWeb- Global Erythropoietin EPO Market with Focus on Asi

Global Erythropoietin EPO Market with Focus on Asia- Industry
Analysis & Outlook 2016-2020
ReportsWeb.com published “Erythropoietin EPO Market” from its database. The report covers
the market landscape and its growth prospects over the coming years. The report also includes
a discussion of the key vendors operating in this market.
Erythropoietin is a substance produced by the kidney that leads to the formation of red blood
cells in the bone marrow. It is a glycoprotein hormone which regulates erythropoiesis (Red
Blood Cell production) . For erythrocyte precursors present in the bone marrow, EPO acts as a
cytokine. Commonly referred to as hematopoietin or hemopoietin, erythropoietin is also known
to have other biological functions, such as involvement in the wound healing cycle and brain's
response to neuronal injury. People suffering from End Stage Renal Disease (ESRD) , HIV or
undergoing chemotherapy are not able to produce enough EPO on their own and thus, are
administered with synthetic or recombinant erythropoietin which has the similar sequence of
amino acids. Recombinant erythropoietin is a kind of therapeutic agent devised using DNA
technology.
On the bases of their molecular structure, EPO drugs can be divided into five categories:
epoetin-alfa, epoetin-beta, epoetin-omega, epoetin-delta and darbepoetin-alfa. Among these
epoetin-alfa and darbepoetin-alfa are most commonly prescribed EPO drugs.
For more information about this report: http://www.reportsweb.com/global-erythropoietin-
epo-market-with-focus-on-asia-industry-analysis-and-outlook-2016-2020
The global EPO drugs market is expected to experience negative growth rate, primarily due to
expiry of patents of two most common EPO drugs, epoetin-alfa and darbepoetin-alfa, allowing
the entry of biosimilars; posing a serious threat to EPO drugs market. However, the Asia-Pacific
region is expected to experience boom period majorly due to improving disposable income and
better government medical reimbursement policies.
The report "Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlook
(2016-2020) " analyzes the development of this market, with focus on the US and Asia-Pacific
markets. The major trends, growth drivers as well as issues being faced by the market are
discussed in detail in this report. The four major players: Johnson & Johnson, Amgen, Roche and
Teva Pharmaceutical Industries Limited are being profiled along with their key financials and
strategies for growth. The report contains a comprehensive analysis of the global EPO market
along with the study of the regional markets.